Birth of a Manufacturing Plant

Mazda Motor Corporation, Toyota | December 23, 2019

Birth of a Manufacturing Plant
Mazda Toyota Manufacturing U.S.A. has quite the fish tale to tell about its $1.6 billion joint venture assembly plant rising in Huntsville, Alabama. Last summer, concerns raised over the spring pygmy sunfish, listed as a threatened species by the U.S. Fish and Wildlife Service, briefly halted prep work at the automotive construction site and ultimately cost the automaker several million dollars. It's a tiny thing, the spring pygmy sunfish, averaging less than an inch in length. As luck would have it, the rare fish is found in just two known locations, both in Alabama and one of which is adjacent to the new Mazda Toyota development. Several conservation groups raised alarms that construction at the auto site would harm sunfish habitat; at one point a lawsuit was threatened, but eventually the two sides in December 2018 reached an agreement in which Mazda Toyota would invest $6 million in conservation efforts related to the sunfish habitat.

Spotlight

3D Printing is a popular Additive Manufacturing process. Electroforming, while less known, is also a typical Additive Manufacturing process. What's the difference between 3D Printing and Electroforming then? Watch this comparison video to find out!

Spotlight

3D Printing is a popular Additive Manufacturing process. Electroforming, while less known, is also a typical Additive Manufacturing process. What's the difference between 3D Printing and Electroforming then? Watch this comparison video to find out!

Related News

VW, AWS Collaborate on a Digital Marketplace to Push Digital Manufacturing

Amazon Web Services, Volkswagen, Automotive manufacturer | July 29, 2020

VW is working with Amazon Web Services to build a marketplace for software applications designed to help the automaker’s factories, like the one pictured above, run faster and more efficiently. Digital marketplaces are now in vogue as a place to bring business buyers and sellers together to research and purchase physical goods. But Volkswagen AG, Europe’s biggest automotive manufacturer and the maker of VW, Audi and other vehicles, also sees a digital marketplace as an ideal way to bring together buyers and sellers of software applications and move the entire process of digital manufacturing even further into the mainstream. Volkswagen, in conjunction with Amazon Web Services, the cloud computing arm of Amazon.com Inc., is building what it bills as the “ultimate app store” for industrial software applications. The store will make available from multiple automotive industry suppliers software apps designed to increase speed and efficiency in developing parts and manufacturing vehicles at the car maker’s 61 production plants and factories around the world.

Read More

MANUFACTURING TECHNOLOGY

Zoomlion Leads Industry to Reach Peak Carbon Emissions and Carbon Neutrality with Green Intelligent Manufacturing and Products

Zoomlion | September 23, 2021

As countries move towards peak carbon emissions and carbon neutrality goals in line with The Paris Agreement, Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion"; 1157.HK) is leading the industry by promoting green transformation and development through building intelligent green factories and continuously upgrading manufacturing processes, striving to contribute to energy conservation, emissions reduction and efficient use of resources. Green Manufacturing The company is investing 100 billion yuan (USD 15.5 billion) to build the Zoomlion Smart Industrial City, based on intelligent production lines and an Internet of Things (IoT) platform, adopting digital technologies to realize full integration of manufacturing factors and intelligent synergy and utilization, and achieving all-round energy conservation and emissions reduction. It's set to become a green and intelligent ecological new city and world-class 'lighthouse' factory. Likewise, the Zoomlion Tower Crane Intelligent Factory - developed based on the sustainable life cycle design approach that utilizes green design, technology, packing, manufacturing and more – integrates 24 intelligent production lines and eight green manufacturing technologies to achieve an all-round green upgrade encompassing welding, dust removal, processing, painting, equipment and drive energy-saving and waste treatment. The green rate of manufacturing technology and processes are 98.7 and 97.3 percent respectively, and the environmental impact rate has reduced to 2.7 percent with VOC emissions decreasing 60 percent year-on-year. Green Products Zoomlion has also released a series of industry-leading green products. In 2020, Zoomlion produced the world's first pure electric truck crane ZTC250N-EV which has a maximum speed of 90km/h and maximum gradeability of 50 percent, while energy cost is only 35 percent that of fuel products in the same class. Zoomlion's new energy product portfolio also includes electric mixer trucks, lithium-ion and hybrid-power aerial work platforms, electric and hydrogen-powered forklifts. Zoomlion will continue a sustainable development strategy and thoroughly implement green measures throughout operations, production, design, R&D and product, promote reaching carbon neutrality goals, and create added value for our customers' living environment, the industry and humankind. About Zoomlion Founded in 1992, Zoomlion Heavy Industry Science & Technology Co., Ltd. (1157.HK) is a high-end equipment manufacturing enterprise that integrates engineering machinery, agricultural machinery, and financial services. The company now sells 568 cutting-edge products from 70 product lines covering 11 significant categories.

Read More

Baxter Biopharma Solutions Announces Novavax COVID-19 Vaccine Sterile Manufacturing Agreement

businesswire | January 11, 2021

Baxter International Inc, a worldwide pioneer in clean medicine creation and conveyance, today declared that Baxter BioPharma Solutions has gone into a consent to give clean assembling administrations to NVX-CoV2373, Novavax' COVID-19 recombinant nanoparticle immunization applicant with Matrix-M™ adjuvant. Baxter BioPharma Solutions is a head contract fabricating association that works in parenteral (injectable) drugs, including antibodies. The understanding is required to propel business scale fabricating basic for the immunization's creation and appropriation in the United Kingdom and European business sectors. Novavax' COVID-19 antibody applicant is at present in stage 3 preliminaries and has not yet been approved or affirmed for use. “The quest to develop vaccines for COVID-19 has reinforced the opportunity for industry partners to work together and contribute their unique capabilities and expertise for the benefit of all,” said Marie Keeley, vice president, Baxter BioPharma Solutions. “We welcome the opportunity to work with an innovative company like Novavax and look forward to helping bring their vaccine candidate to the market.” As per Novavax, NVX-CoV2373 contains a full-length, prefusion spike protein made utilizing Novavax' recombinant nanoparticle innovation and the organization's restrictive saponin-based Matrix-M™ adjuvant. The cleaned protein is encoded by the hereditary arrangement of the SARS-CoV-2 spike (S) protein and is created in creepy crawly cells. It can neither reason COVID-19 sickness nor would it be able to reproduce, is steady at 2°C to 8°C and is made in a prepared to-utilize fluid definition that grants circulation utilizing standard immunization production network channels. “Our priority is to bring a safe, effective COVID-19 vaccine to people around the world,” said Rick Crowley, executive vice president, chief operations officer, Novavax. “Partners like Baxter BioPharma Solutions are enabling Novavax to quickly establish a commercial supply chain network to ensure access for global populations, and ultimately help bring about an end to the global COVID-19 pandemic.” Baxter's assembling administrations for NVX-CoV2373 will happen at its cutting edge office in Halle/Westfalen, Germany. The site has wide sterile assembling capacities and regions of center, offers current great assembling rehearses (cGMP) fabricating with committed creation zones and is intended to convey items with ideal proficiency and speed to advertise. Baxter's as of late extended Halle/Westfalen office has been in activity for over 60 years. About Baxter's BioPharma Solutions Business Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise, sterile manufacturing solutions, parenteral delivery systems and customized support services needed to meet the unique challenges that parenteral products face. About Baxter Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

Read More